title: Potential new treatments for EGFR-inhibitor-resistant NSCLC.
authors.forename: Farhat
authors.initials: F
authors.lastname: Yaqub
mesh_terms: D000178:Acrylamides / Q000627:therapeutic use*; D000814:Aniline Compounds / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D017321:Clinical Trials, Phase I as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D007211:Indoles; D011743:Pyrimidines
chemical_list: D000178:Acrylamides; D000814:Aniline Compounds; D066246:ErbB Receptors; C000596361:osimertinib; D007211:Indoles; D011743:Pyrimidines; C512478:EGFR protein, human